Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum.

Le Loarer F, Laffont S, Lesluyes T, Tirode F, Antonescu C, Baglin AC, Delespaul L, Soubeyran I, Hostein I, Pérot G, Chibon F, Baud J, Le Guellec S, Karanian M, Costes-Martineau V, Castain C, Eimer S, Le Bail B, Wassef M, Coindre JM.

Am J Surg Pathol. 2019 Jun;43(6):747-754. doi: 10.1097/PAS.0000000000001238.

PMID:
30829729
2.

Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.

Bioulac-Sage P, Sempoux C, Frulio N, Le Bail B, Blanc JF, Castain C, Laurent C, Trillaud H, Chiche L, Balabaud C.

Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):12-19. doi: 10.1016/j.clinre.2018.07.007. Epub 2018 Sep 10.

PMID:
30213653
3.

Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.

Balabaud C, Laurent C, Le Bail B, Castain C, Possenti L, Frulio N, Chiche L, Blanc JF, Bioulac-Sage P.

Liver Int. 2018 Jul;38(7):1273-1279. doi: 10.1111/liv.13667. Epub 2018 Jan 17.

PMID:
29265678
4.

Fatal Acute Liver Failure as a Consequence of Regorafenib Treatment in a Metastatic Colon Cancer.

Béchade D, Desjardin M, Castain C, Bernard PH, Fonck M.

Case Rep Oncol. 2017 Aug 29;10(2):790-794. doi: 10.1159/000479732. eCollection 2017 May-Aug.

5.

Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.

Saldarriaga J, Bisig B, Couchy G, Castain C, Zucman-Rossi J, Balabaud C, Sempoux C, Bioulac-Sage P.

Histopathology. 2017 Dec;71(6):989-993. doi: 10.1111/his.13283. Epub 2017 Oct 6.

PMID:
28618047
6.

BRAF V600E mutational status in bile duct adenomas and hamartomas.

Pujals A, Bioulac-Sage P, Castain C, Charpy C, Zafrani ES, Calderaro J.

Histopathology. 2015 Oct;67(4):562-7. doi: 10.1111/his.12674. Epub 2015 Mar 31.

PMID:
25704541
7.

Steatotic hepatocellular adenomas with different phenotypic subtypes: a case report.

Alberti N, Castain C, Crombe A, Frulio N.

Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):e17-22. doi: 10.1016/j.clinre.2014.08.007. Epub 2014 Sep 26.

PMID:
25260568
8.

Liver metastases within focal nodular hyperplasias.

Alberti N, Castain C, Frulio N, Crombe A, Trillaud H.

Clin Res Hepatol Gastroenterol. 2015 Jun;39(3):280-1. doi: 10.1016/j.clinre.2014.06.010. Epub 2014 Aug 22. No abstract available.

PMID:
25159035
9.

Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.

Cassinotto C, Lapuyade B, Mouries A, Hiriart JB, Vergniol J, Gaye D, Castain C, Le Bail B, Chermak F, Foucher J, Laurent F, Montaudon M, De Ledinghen V.

J Hepatol. 2014 Sep;61(3):550-7. doi: 10.1016/j.jhep.2014.04.044. Epub 2014 May 9.

PMID:
24815876
10.

[Incidental intraplacental gestational choriocarcinoma on a full-term placenta].

Sauvestre F, Carles D, Faure M, Taillat F, Le Boulanger F, Castain C, André G, Pelluard F.

Ann Pathol. 2014 Apr;34(2):119-23. doi: 10.1016/j.annpat.2014.02.009. Epub 2014 Mar 16. French.

PMID:
24703021
11.

BRAF V600E mutations in bile duct adenomas.

Pujals A, Amaddeo G, Castain C, Bioulac-Sage P, Compagnon P, Zucman-Rossi J, Azoulay D, Leroy K, Zafrani ES, Calderaro J.

Hepatology. 2015 Jan;61(1):403-5. doi: 10.1002/hep.27133. Epub 2014 May 19. No abstract available.

PMID:
24634053
12.

Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?

Castain C, Sempoux C, Brunt EM, Causse O, Heitzmann A, Hernandez-Prera JC, Le Bail B, Schirmacher P, Thung SN, Balabaud C, Bioulac-Sage P.

Histopathology. 2014 May;64(6):890-5. doi: 10.1111/his.12326. Epub 2014 Jan 24.

PMID:
24236804
13.

[Placental pathology of uteroplacental vascular deficiency].

Carles D, Pelluard F, André G, Naudion S, Poingt M, Castain C, Sauvestre F.

Ann Pathol. 2013 Aug;33(4):230-6. doi: 10.1016/j.annpat.2013.04.018. Epub 2013 Jul 31. Review. French.

PMID:
23954115
14.

Sorafenib-mediated targeting of the AAA⁺ ATPase p97/VCP leads to disruption of the secretory pathway, endoplasmic reticulum stress, and hepatocellular cancer cell death.

Yi P, Higa A, Taouji S, Bexiga MG, Marza E, Arma D, Castain C, Le Bail B, Simpson JC, Rosenbaum J, Balabaud C, Bioulac-Sage P, Blanc JF, Chevet E.

Mol Cancer Ther. 2012 Dec;11(12):2610-20. doi: 10.1158/1535-7163.MCT-12-0516. Epub 2012 Oct 5.

Supplemental Content

Loading ...
Support Center